Core Laboratories NV (CLB) β†’ Stock, financial statements
Advertising

Core Laboratories NV

19.83 USD -0.37 (-1.40%)
Jul 01 πŸ‡ΊπŸ‡Έ NYSE CLB
Dividends
Favorites
  • CLB Ticker
  • πŸ‡ΊπŸ‡Έ NYSE Exchange
  • 4,700 Employees
2 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements β€” Core Laboratories NV

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
490M 670M 700M 660M 590M
Cost Of Revenue
370M 500M 500M 470M 440M
Gross Profit
110M 170M 200M 190M 150M
Research and Development
0 0 0 0 0
Selling General and Admin
34M 48M 63M 48M 39M
Operating Expense
430M 570M 580M 550M 510M
Operating Income
58M 100M 120M 110M 86M
Other Income Expense Net
0 0 0 0 0
EBIT
58M 100M 120M 110M 86M
Interest Income
14M 15M 13M 11M 12M
Pretax Income
-91M 82M 110M 100M 75M
Income Tax
5.9M -12M 25M 19M 11M
Minority Interest
140K 130K 260K -29K -36K
Net Income
-98M 100M 80M 83M 64M
Net Income Basic
-98M 100M 80M 83M 64M
20 ← 16 2020 2019 2018 2017 2016
Current cash
14M 11M 13M 14M 15M
Short term investments
21M 22M 29M 19M 17M
Receivables
93M 140M 140M 140M 120M
Inventory
38M 50M 46M 33M 34M
Other current assets
21M 22M 29M 19M 17M
Current assets
170M 220M 230M 210M 190M
Long term investments
400M 550M 420M 380M 390M
Property plant equipment
120M 120M 120M 120M 130M
Goodwill
0 210M 220M 180M 180M
Intangible assets
110M 17M 13M 9.4M 9.9M
Other assets
5M 4.9M 5.9M 5.3M 4.8M
Total assets
570M 770M 650M 580M 570M
Accounts payable
23M 36M 41M 42M 34M
Current long term debt
0 0 0 0 0
Other current liabilities
67M 76M 61M 63M 70M
Total current liabilities
90M 110M 100M 110M 100M
Long term debt
260M 310M 290M 230M 220M
Other liabilities
28M 33M 37M 46M 45M
Minority Interest
4.1M 4.3M 4.1M 3.9M 3.9M
Total Liabilities
500M 600M 490M 440M 420M
Common stock
44M 44M 44M 44M 43M
Retained earning
50M 160M 160M 170M 190M
Treasury stock
-14M -29M -53M -76M -81M
Capital surplus
β€’ β€’ β€’ β€’ β€’
Shareholder equity
72M 180M 160M 140M 150M
Net tangible assets
-37M -53M -76M -44M -38M
20 ← 16 2020 2019 2018 2017 2016
Net Income
-98M 100M 80M 83M 64M
Depreciation
21M 23M 23M 25M 27M
Changes in receivables
-45M -5M 2.5M 20M -32M
Changes in inventories
-12M 4.5M 12M -400K -7.2M
Cash change
2.7M -2M -1.3M -360K -7.7M
Cash flow
58M 90M 110M 120M 130M
Capital expenditures
-12M -22M -23M -19M -12M
Investments
β€’ β€’ β€’ β€’ β€’
Investing activity other
β€’ β€’ β€’ β€’ β€’
Total investing cash flows
-7.9M -5.7M -71M -21M -15M
Dividends paid
β€’ β€’ β€’ β€’ β€’
Net borrowings
220M 270M 250M 190M 180M
Other financing cash flows
β€’ β€’ β€’ β€’ β€’
Cash flow financing
-63M -86M -42M -100M -120M
Exchange rate effect
β€’ β€’ β€’ β€’ β€’

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.